3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, Large B-Cell, Diffuse
10
Recurrence
8
Lymphoma, Non-Hodgkin
8
Lymphoma, B-Cell
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Lymphoma
6
Lymphoma, T-Cell, Peripheral
4
Burkitt Lymphoma
4
Multiple Myeloma
3
Leukemia, Myeloid, Acute
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Hodgkin Disease
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Ovarian Neoplasms
2
Myelodysplastic Syndromes
2
Melanoma
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Thrombosis
1
Testicular Neoplasms
1
Strabismus
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Sarcoma
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Osteosarcoma
1
Neoplasms
1
Interventions
Injections
1
Clopidogrel
1
Aspirin
1
Anticoagulants
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ischemic Stroke
×
Injections
×
Lymphoid
×
Clear all
NCT05507645
2024-09-05
PUMICE
Beijing Tiantan Hospital
Phase 3
Completed
1,446 enrolled